News | February 25, 2026
Lupin launches generic Brivaracetam oral solution in US to treat epilepsy
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
Brivaracetam is the bioequivalent to Briviact Oral Solution, 10 mg/mL, of UCB
Nadda underlined that India’s policy framework is aligned with this transformation
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
200+ HR leaders and CXOs convened to discuss workforce health, preventive care, and organisational wellbeing as strategic business priorities
Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpoints
The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner
Net sales reached CHF 1,327.8 million, up 2.6% year-on-year in Swiss francs, or 4.3% at constant exchange rates
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
ANYRA is India’s first indigenously developed Aflibercept 2 mg biosimilar
Bosentan 32 mg tablets for oral suspension are indicated for the treatment of Pulmonary Arterial Hypertension
Subscribe To Our Newsletter & Stay Updated
